Pharmacotherapy of narcotic dependence.
D002047:Buprenorphine / Q000627:therapeutic use; D003496:Cyclazocine / Q000627:therapeutic use; D011431:Dextropropoxyphene / Q000627:therapeutic use; D004157:Diphenoxylate / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D009270:Naloxone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009294:Narcotics; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011379:Prognosis; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000188:drug therapy*
D009292:Narcotic Antagonists; D009294:Narcotics; D009270:Naloxone; D002047:Buprenorphine; D004157:Diphenoxylate; D003496:Cyclazocine; D011431:Dextropropoxyphene; D008691:Methadone